The CIGNA Co. (CI) Stock Rating Reaffirmed by Cowen and Company

The CIGNA Co. (CI) Stock Rating Reaffirmed by Cowen and Company

A number of other analysts have also issued reports on the company. Stifel Nicolaus lifted their target price on CIGNA from $170.00 to $175.00 and gave the stock a “buy” rating in a research report on Monday, May 15th. Royal Bank of Canada lifted their target price on CIGNA from $172.00 to $177.00 and gave the stock an “outperform” rating in a research report on Monday, May 15th. Jefferies Group LLC lifted their target price on CIGNA from $178.00 to $183.00 and gave the stock a “buy” rating in a research report on Monday, May 15th. Deutsche Bank AG lifted their target price on CIGNA from $172.00 to $175.00 and gave the stock a “buy” rating in a research report on Wednesday, May 10th. Finally, Zacks Investment Research raised CIGNA from a “hold” rating to a “buy” rating and set a $175.00 target price on the stock in a research report on Tuesday, April 25th. Two research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. CIGNA presently has an average rating of “Buy” and a consensus target price of $168.79.

CIGNA Co. (NYSE:CI)‘s stock had its “outperform” rating reissued by investment analysts at Cowen and Company in a research report issued on Thursday. They currently have a $185.00 target price on the health services provider’s stock, up from their previous target price of $160.00. Cowen and Company’s price objective would indicate a potential upside of 12.49% from the stock’s current price.

CIGNA (CI) opened at 164.46 on Thursday. CIGNA has a 52-week low of $115.03 and a 52-week high of $165.16. The firm has a market capitalization of $42.10 billion, a PE ratio of 21.96 and a beta of 0.53. The stock’s 50 day moving average price is $159.01 and its 200 day moving average price is $147.98.

In other CIGNA news, insider Jason D. Sadler sold 4,213 shares of CIGNA stock in a transaction that occurred on Monday, April 10th. The stock was sold at an average price of $152.01, for a total value of $640,418.13. Following the completion of the transaction, the insider now directly owns 36,231 shares in the company, valued at $5,507,474.31. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, EVP Lisa R. Bacus sold 11,455 shares of CIGNA stock in a transaction that occurred on Wednesday, May 24th. The shares were sold at an average price of $161.57, for a total value of $1,850,784.35. Following the completion of the transaction, the executive vice president now owns 24,753 shares of the company’s stock, valued at $3,999,342.21. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 36,580 shares of company stock valued at $5,836,087. 1.20% of the stock is currently owned by insiders. Institutional investors have recently modified their holdings of the stock. American Beacon Advisors Inc. bought a new position in shares of CIGNA during the first quarter worth approximately $102,000. Live Your Vision LLC bought a new position in shares of CIGNA during the third quarter worth approximately $113,000. Baystate Wealth Management LLC increased its position in shares of CIGNA by 436.1% in the first quarter. Baystate Wealth Management LLC now owns 772 shares of the health services provider’s stock worth $116,000 after buying an additional 628 shares during the last quarter. Founders Capital Management bought a new position in shares of CIGNA during the first quarter worth approximately $117,000. Finally, Mckinley Capital Management LLC Delaware bought a new position in shares of CIGNA during the first quarter worth approximately $122,000. Institutional investors own 85.65% of the company’s stock.

CIGNA Company Profile Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.new TradingView.widget({ “height”: 400, “width”: 625, “symbol”: “CI”, “interval”: “D”, “timezone”: “Etc/UTC”, “theme”: “White”, “style”: “1”, “locale”: “en”, “toolbar_bg”: “#f1f3f6”, “enable_publishing”: false, “hideideas”: true, “referral_id”: “2588”});

Receive News & Ratings for CIGNA Co. Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for CIGNA Co. and related companies with MarketBeat.com’s FREE daily email newsletter.

Related posts

Leave a Comment